Guardant Health (NASDAQ: GH)
Guardant Health Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Guardant Health Company Info
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Palo Alto, CA.
News & Analysis
Why Guardant Health Stock Blasted 13% Higher on Thursday
Guardant Delivers Healthy Q3 Growth
The oncology specialist reported stronger third quarter results, powered by strategic product launches and favorable Medicare reimbursement rates.
Why Guardant Health Stock Was the Picture of Health Today
There's nothing like free publicity to help goose the sales of a relatively new product.
Why Guardant Health Stock Just Crashed 10%
Guardant Health needs cash. Until it can get it from selling enough services, it must sell its own shares instead.
Guardant Health Q2 Losses Rise Amid Revenue Boom
Guardant Health showed strong revenue growth but reported increasing net losses in its latest earnings release.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions.
1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years
This company's fight against a deadly disease could pay off.
Why Guardant Health Stock Jumped 15% This Week
The precision oncology leader benefited from a pair of positive analyst notes this week. Here's what investors need to know.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.